Global Conjugate Vaccine Competitive Landscape Professional Research Report 2024
Description
Global Conjugate Vaccine Competitive Landscape Professional Research Report 2024
Research Summary
A conjugate vaccine is a type of vaccine that combines a weak antigen from a bacteria or virus with a carrier protein to enhance the body＇s immune response. The weak antigen is typically from a bacterial capsule or a virus＇s surface protein that is not effective in eliciting a strong immune response on its own. By linking the weak antigen to a carrier protein, the immune system recognizes it more effectively, resulting in a robust immune response and the production of antibodies. Conjugate vaccines are widely used to protect against bacterial infections, particularly those caused by bacteria with polysaccharide capsules, such as Haemophilus influenzae type b (Hib), Streptococcus pneumoniae, and Neisseria meningitidis. These vaccines have been instrumental in reducing the incidence of serious bacterial infections, especially in young children and vulnerable populations.
According to DIResearch's in-depth investigation and research, the global Conjugate Vaccine market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Conjugate Vaccine include Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biologic, Bharat Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Conjugate Vaccine. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Conjugate Vaccine market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Conjugate Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Conjugate Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Conjugate Vaccine Include:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Bharat Biotech
Conjugate Vaccine Product Segment Include:
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Conjugate Vaccine Product Application Include:
Children
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Conjugate Vaccine Industry PESTEL Analysis
Chapter 3: Global Conjugate Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Conjugate Vaccine Major Regional Market Size and Forecast Analysis
Chapter 5: Global Conjugate Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Conjugate Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Conjugate Vaccine Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Conjugate Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Conjugate Vaccine Product by Type
- 1.2.1 Global Conjugate Vaccine Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Hib Vaccine
- 1.2.3 Meningococcal Vaccine
- 1.2.4 Pneumococcal Vaccine
- 1.2.5 Others
- 1.3 Conjugate Vaccine Product by Application
- 1.3.1 Global Conjugate Vaccine Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Children
- 1.3.3 Adult
- 1.4 Global Conjugate Vaccine Market Revenue Analysis (2019-2030)
- 1.5 Conjugate Vaccine Market Development Status and Trends
- 1.5.1 Conjugate Vaccine Industry Development Status Analysis
- 1.5.2 Conjugate Vaccine Industry Development Trends Analysis
- 2 Conjugate Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Conjugate Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Conjugate Vaccine Market Analysis by Regions
- 4.1 Conjugate Vaccine Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Conjugate Vaccine Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Conjugate Vaccine Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Conjugate Vaccine Revenue Forecast by Region (2025-2030)
- 5 Global Conjugate Vaccine Market Size by Type and Application
- 5.1 Global Conjugate Vaccine Market Size by Type
- 5.2 Global Conjugate Vaccine Market Size by Application
- 6 North America
- 6.1 North America Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Conjugate Vaccine Market Size by Type
- 6.4 North America Conjugate Vaccine Market Size by Application
- 6.5 North America Conjugate Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Conjugate Vaccine Market Size by Type
- 7.4 Europe Conjugate Vaccine Market Size by Application
- 7.5 Europe Conjugate Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Conjugate Vaccine Market Size by Type
- 8.4 China Conjugate Vaccine Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Conjugate Vaccine Market Size by Type
- 9.4 APAC (excl. China) Conjugate Vaccine Market Size by Application
- 9.5 APAC (excl. China) Conjugate Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Conjugate Vaccine Market Size by Type
- 10.4 Latin America Conjugate Vaccine Market Size by Application
- 10.5 Latin America Conjugate Vaccine Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Conjugate Vaccine Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Conjugate Vaccine Market Size by Type
- 11.4 Middle East & Africa Conjugate Vaccine Market Size by Application
- 11.5 Middle East & Africa Conjugate Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Conjugate Vaccine Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Conjugate Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Conjugate Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Pfizer
- 13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Pfizer Conjugate Vaccine Product Portfolio
- 13.1.3 Pfizer Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 GSK
- 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 GSK Conjugate Vaccine Product Portfolio
- 13.2.3 GSK Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Sanofi
- 13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Sanofi Conjugate Vaccine Product Portfolio
- 13.3.3 Sanofi Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Merck
- 13.4.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Merck Conjugate Vaccine Product Portfolio
- 13.4.3 Merck Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Walvax Biotechnology
- 13.5.1 Walvax Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Walvax Biotechnology Conjugate Vaccine Product Portfolio
- 13.5.3 Walvax Biotechnology Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Royal (Wuxi) Bio-Pharmaceutical
- 13.6.1 Royal (Wuxi) Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolio
- 13.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Zhifei Biologic
- 13.7.1 Zhifei Biologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Zhifei Biologic Conjugate Vaccine Product Portfolio
- 13.7.3 Zhifei Biologic Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Bharat Biotech
- 13.8.1 Bharat Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Bharat Biotech Conjugate Vaccine Product Portfolio
- 13.8.3 Bharat Biotech Conjugate Vaccine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Conjugate Vaccine Industry Chain Analysis
- 14.2 Conjugate Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Conjugate Vaccine Typical Downstream Customers
- 14.4 Conjugate Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
